The efficacy of homoharringtonine in pediatric acute myeloid leukemia: findings from the Chinese Children's Leukemia Group-AML 2015 Study.
作者信息
Catueno Samanta, Haddad Fadi G, Cuglievan Branko
机构信息
Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Transl Pediatr. 2024 Feb 29;13(2):376-379. doi: 10.21037/tp-23-536. Epub 2024 Feb 23.
Abstract
摘要
相似文献
1
The efficacy of homoharringtonine in pediatric acute myeloid leukemia: findings from the Chinese Children's Leukemia Group-AML 2015 Study.
Transl Pediatr. 2024 Feb 29;13(2):376-379. doi: 10.21037/tp-23-536. Epub 2024 Feb 23.
2
Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies.
Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1):13-21. doi: 10.1016/j.clml.2014.09.011. Epub 2014 Oct 5.
3
The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China.
Pediatr Hematol Oncol. 2021 Mar;38(2):97-107. doi: 10.1080/08880018.2020.1820649. Epub 2020 Oct 5.
4
Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells.
Exp Cell Res. 2019 Mar 15;376(2):114-123. doi: 10.1016/j.yexcr.2019.02.008. Epub 2019 Feb 11.
5
Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway.
Biochem Pharmacol. 2021 Jun;188:114538. doi: 10.1016/j.bcp.2021.114538. Epub 2021 Apr 6.
6
Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia.
Front Med. 2019 Jun;13(3):388-397. doi: 10.1007/s11684-018-0624-1. Epub 2019 Jun 11.
7
Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia.
Front Med. 2019 Jun;13(3):378-387. doi: 10.1007/s11684-018-0658-4. Epub 2019 Jun 11.
8
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia.
J Transl Med. 2022 Jul 6;20(1):299. doi: 10.1186/s12967-022-03497-2.
9
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.
J Clin Oncol. 2023 Nov 1;41(31):4881-4892. doi: 10.1200/JCO.22.02836. Epub 2023 Aug 2.
10
Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia.
Leuk Lymphoma. 2020 May;61(5):1084-1096. doi: 10.1080/10428194.2017.1390229. Epub 2018 Jan 15.
引用本文的文献
1
Characterization of Acute Myeloid Leukemia With RUNX1/RUNX1T1 Gene Rearrangement: Clinical, Hematological, and Morphological Features.
Cureus. 2024 Nov 29;16(11):e74760. doi: 10.7759/cureus.74760. eCollection 2024 Nov.
本文引用的文献
1
Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.
Acta Pharmacol Sin. 2024 Mar;45(3):633-645. doi: 10.1038/s41401-023-01196-2. Epub 2023 Nov 28.
2
Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia.
Cancers (Basel). 2023 Aug 18;15(16):4171. doi: 10.3390/cancers15164171.
3
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.
J Clin Oncol. 2023 Nov 1;41(31):4881-4892. doi: 10.1200/JCO.22.02836. Epub 2023 Aug 2.
4
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
Semin Cancer Biol. 2023 Jul;92:84-101. doi: 10.1016/j.semcancer.2023.03.009. Epub 2023 Mar 31.
5
Comprehensive molecular understanding of pediatric acute myeloid leukemia.
Int J Hematol. 2023 Feb;117(2):173-181. doi: 10.1007/s12185-023-03533-x. Epub 2023 Jan 18.
6
Current and emerging pharmacotherapy for the treatment of childhood acute myeloid leukemia.
Expert Opin Pharmacother. 2022 Dec;23(17):1915-1925. doi: 10.1080/14656566.2022.2145186. Epub 2022 Nov 13.
7
Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.
Molecules. 2022 Jun 18;27(12):3911. doi: 10.3390/molecules27123911.
8
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
J Clin Oncol. 2022 Jun 20;40(18):2023-2035. doi: 10.1200/JCO.21.01612. Epub 2022 Mar 29.
9
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
JAMA Oncol. 2022 Jan 1;8(1):79-87. doi: 10.1001/jamaoncol.2021.5206.
10
Treatment of acute myeloid leukemia in children: A practical perspective.
Pediatr Blood Cancer. 2021 Jul;68(7):e28979. doi: 10.1002/pbc.28979. Epub 2021 Apr 12.
Zotero 插件